-
Lack of Specificity of LC-MS/MS Based Urinary Biomarkers for Polyomavirus BK Nephropathy (BKPyVN).
-
Lack of Utility of KDPI in Dual Kidneys from Donors at the Extremes of Age.
-
Lack of Xenograft Recipient Monitoring by Telemetry Lets Infection Go Unchecked and Trigger Coagulopathy.
-
Lactate Level Immediate Post-Liver Transplantation Is a Predictor of Early Allograft Dysfunction.
-
Landscape of Multiple Donations from a Living Donor in the US.
-
Laparoscopic Sleeve Gastrectomy Improves Renal Transplant Candidacy and Posttransplant Outcomes in Morbidly Obese Patients.
-
Largest US Series of Minimally Invasive Full and Laparoscopy-Assisted Living Donor Hepatectomy.
-
Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
-
Lessons Learned from Simultaneous Biopsies of Both Kidney and Pancreas Grafts in Recipients of Simultaneous Kidney-Pancreas Transplants.
-
Life Confocal Imaging of Murine Liver Biopsies as Novel Tool to Assess Graft Viability Prior to Transplantation.
-
Life Threatening Disparities in Calculated MELD Due to Variation in Laboratory Methods within a UNOS Region.
-
Limited Impact of Pre-Existing Donor Specific HLA Antibodies on Long Term Survival After First Adult Liver Transplantation.
-
Lipid Abnormalities and Cardiovascular Events After Early Conversion to Everolimus in Kidney Transplant Recipients with Pretransplant Diabetes: 24-Month Analysis from Elevate Study.
-
Lipid Catabolism Provides Alternative Energy Source and Compensates for Mitochondrial Dysfunction in Reperfused Rat Kidneys After Ischaemia.
-
Live Donor (LDTx) HIV(+) Kidney Transplantation Improves Allograft Survival vs. Deceased Donor (CRD) Transplantation.
-
Live Donor Liver Transplantation Using Grafts with More Than Two Bile Ducts – Does It Affect Patient Outcome?
-
Liver Allograft Hepatitis and Graft Loss After Hepatitis C Clearance.
-
Liver Mesenchymal Stem Cells Inhibit T Cell Alloresponses.
-
Liver Regeneration in Porcine Hepatectomy Model.
-
Liver Retransplantation: The Largest Post MELD Single Center Experience.
-
Liver Targeted Expression of a Single Allogeneic MHC I Molecule Promotes Tolerance to Pancreatic Islet Allograft by Inducing Specific CD8+ Regulatory T Cells in Mice.
-
Liver Transplant Recipients Undergoing Non-Transplant Surgeries and Everolimus Use as Primary Immunosuppressant- Busting the Myth of Wound Infection Due to mTOR Inhibitors.
-
Liver Transplantation Beyond MELD 40.
-
Liver Transplantation for Adolescents with Biliary Atresia in the PELD/MELD Era: An Analysis of the UNOS Database.
-
Liver Transplantation for Babies Weighing Less Than 10 kg.
-
Liver Transplantation Outcomes Using Anti-Thymocyte Globulin Induction in Patients with Autoimmune Hepatitis.
-
Liver Transplantation Tolerance Using Outbred Mice.
-
Liver Transplantation Using Pediatric versus Adult Donor Grafts in Adult Recipients.
-
Living and Deceased Donor Uterus Transplantation – The 2-Arm Czech Uterus Transplant Trial: The First Year Report with Four Cases Done so Far.
-
Living Donor Liver Transplantation for Alcoholic Liver Disease.
-
Living Kidney Donor Pharmaceutical Care Needs Identified Through Linked Transplant Registry and Pharmacy Claims Data.
-
Living Kidney Donors: Battling High Attrition Rates During Evaluation Process.
-
Living Kidney Transplant: The Influence of Intraoperative Hemodynamics on Delayed Graft Function.
-
Long Term Outcomes of Adult Kidney Transplants from Small Single Pediatric Donors Are Equivalent to Standard Criteria Donors.
-
Long Wait Time Regions for Liver Transplantation for HCC Have a Higher Cumulative Incidence of Death.
-
Long-Term Analysis of Combined Liver-Lung Transplant Outcomes at a Single-Center.
-
Long-Term Clinical Outcomes of Kidney Transplant Recipients with Body-Size Mismatch Between Recipient and Donor.
-
Long-Term Consequences of Post-Donation Preeclampsia.
-
Long-Term Drug-Free Survival of Tiny Cynomolgus Islet Allografts.
-
Long-Term Follow-Up of the Safety and Effects of Bariatric Surgery on Immunosuppression in Post-Transplant Patients.
-
Long-Term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology.
-
Long-Term Liver and Kidney Survival Following Combined Liver-Kidney Transplantation, with or without Preformed Donor-Specific Antibodies.
-
Long-Term Malignancy Risk in Kidney Transplant Recipients Treated with Cyclophosphamide Pre-Transplant for Native Glomerular Disease.
-
Long-Term Outcome of Antibody-Mediated Rejection Due to Pre-Existing vs. De Novo DSA in Kidney Allograft Recipients.
-
Long-Term Outcomes After Liver Transplantation (tx) with Everolimus (EVR) and Mycophenolic Acid (MPA) in a Calcineurin Inhibitor-Free Regimen: The CERTITUDE Trial.
-
Long-Term Outcomes Among Slow versus Delayed or Immediate Graft Function Kidney Transplant Recipients: A Single-Center Experience.
-
Long-Term Outcomes in HIV(+) Kidney Re-Tranpslant (ReTx) Recipients vs. Primary Transplant (PrimTx) Recipients.
-
Long-Term Outcomes of Kidney Transplant Recipients with Primary Idiopathic Focal Segmental Glomerulosclerosis (FSGS).
-
Long-Term Outcomes of Renal Function in Pediatric Living Related Intestinal Transplantation.
-
Long-Term Pediatric Live-Donor Liver Transplantation Survivors: Patient and Allograft Outcomes.
-
Long-Term Persistence of Anti-HLA Antibodies in Renal Trasplant Recipients: Risk Factors and Impact on Clinical Course.
-
Long-Term Preservation of Renal Function in Liver Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Delayed Initiation of Calcineurin Inhibitors.
-
Longer Anastomotic Time Leads to Delayed Graft Function.
-
Longer Ischemic Time Is Associated with Late Graft Dysfunction in Pediatric Heart Transplant Recipients.
-
Longer Pre-Transplant Dialysis Exposure Is More Frequent in Living Donor Kidney Transplantation (LDTX) Involving Lower Income Donor and Recipients and Is Associated with an Increased Risk of LDTX Failure.
-
Longitudinal Study of Donor Specific Antibodies in a Pediatric Kidney Transplant Population; Response to Optimization of Anti-Proliferative Therapy.
-
Loss of Bat3 Could Promote Transplant Tolerance by Regulating CD4 + T Cells Function.
-
Low Dose Valganciclovir for CMV Prophylaxis in the First Year of Kidney Transplantation.
-
Low Incidence of Acute Rejection within the Six Months After Transplantation in HIV Recipients Treated with Raltegravir, the ANRS 153 Treve Trial.
-
Low Level Early Onset De Novo DSA's May Not Portend Early Graft Dysfunction in Kidney Transplant Recipients.
-
Low Level Light Laser Treatment Reduces Macrophage Retention and ROS Levels Following Tissue Injury.
-
Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate Risk Renal Transplants: A Single Center Experience.
-
Lower Incidence of DSA-Induced Chronic Antibody-Mediated Rejection in Abo-Incompatible Renal Transplantation.
-
Lower Mean Tacrolimus Troughs Increase Risk of De Novo Donor-Specific Antibodies in the First Year of Kidney Transplant.
-
Lower Rates of Living Donation Among Transplant Centers Located in the Stroke Belt.
-
Lung Preservation Solution Exposure at Cardiac Procurement Is Associated Increased Incidence of Coronary Arterial Vasculopathy.
-
Lung Transplant Recipient Travel Distance to Transplant Center Does Not Impact Survival.
-
Lymph Node Stromal Laminins Differentially Regulate T Cell Activation.
-
Lymphoid Isolation as an Adjuvant Maneuver for Belatacept-Based Immunotherapy.
-
Lymphoproliferative Disorders After Renal Transplantation Along Two Decades: A Large Longitudinal Study.
-
Lymphotoxin (LT) β Receptor-Mediated Non-Classical NFκB Signaling in Lymphatic Endothelial Eells (LEC) is Required for Homeostatic T Cell Migration.
2017 American Transplant Congress
April 29-May 3, 2017 in Chicago, IL